FOX JONATHAN C (See Remarks) sold 1.1% of their position (4.23K shares) of EIDOS THERAPEUTICS, INC. on the open market
Open‑market sale worth $212.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/16/2020ACC: 0000899243-20-025364
Officer· See Remarks
Since Nov 2018
-4.23K
Net shares
Net seller
$212.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
4.23K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−111.00
Price / share
$50.00
Trade value
$5.55K
% of position
0.0%
9/14/2020
387.67K→387.56K
Common Stock
Indirect
Shares
−1K
Price / share
$50.06
Trade value
$50.06K
% of position
0.3%
9/15/2020
387.56K→386.56K
Common Stock
Indirect
Shares
−3.12K
Price / share
$50.16
Trade value
$156.61K
% of position
0.8%
9/16/2020
386.56K→383.44K
Total
Net shares
−4.23K
Net value
-$212.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/14/2020 | S · Sale | −111.00 | $50.00 | $5.55K | 0.0% | 387.67K | 387.56K |
| Common Stock Indirect | 9/15/2020 | S · Sale | −1K | $50.06 | $50.06K | 0.3% | 387.56K | 386.56K |
| Common Stock Indirect | 9/16/2020 | S · Sale | −3.12K | $50.16 | $156.61K | 0.8% | 386.56K | 383.44K |
| Total | −4.23K | -$212.22K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned3.29K
Total
3.29K direct3.29K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.29K | Direct |
| Total | 3.29K | 3.29K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported